STOCK TITAN

[8-K] Pluri Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Lennox International Inc. (LII) – Form 144 filing discloses that John W. Norris III intends to sell 3,190 shares of the company’s common stock. The planned transaction, to be executed through Morgan Stanley Smith Barney LLC, carries an estimated aggregate market value of $1.92 million based on the quoted market price at the time of filing. The shares represent roughly 0.009% of the 35.48 million shares outstanding, signalling a limited dilution impact.

The shares were originally received as a gift on 23 Jul 2009; thus, the filing satisfies Rule 144’s disclosure requirement for the resale of restricted or control securities. An accompanying table shows that the same holder already sold an identical 3,190-share block on 1 Jul 2025 for gross proceeds of $1.91 million, indicating continued disposition of gifted shares. The expected sale date for the new block is 3 Jul 2025 on the NYSE.

Because the filing is a notice of intent—not a confirmation of execution—and the volume is immaterial relative to total shares, the market impact is likely minimal. Nonetheless, recurring insider sales can attract investor attention regarding insider sentiment.

Lennox International Inc. (LII) – Comunicazione secondo il Modulo 144 rivela che John W. Norris III intende vendere 3.190 azioni del capitale ordinario della società. L’operazione prevista, che sarà effettuata tramite Morgan Stanley Smith Barney LLC, ha un valore di mercato complessivo stimato di 1,92 milioni di dollari basato sul prezzo di mercato quotato al momento della comunicazione. Le azioni rappresentano circa il 0,009% delle 35,48 milioni di azioni in circolazione, indicando un impatto di diluizione limitato.

Le azioni sono state originariamente ricevute come donazione il 23 luglio 2009; pertanto, la comunicazione soddisfa il requisito di divulgazione previsto dalla Regola 144 per la rivendita di titoli soggetti a restrizioni o di controllo. Una tabella allegata mostra che lo stesso detentore aveva già venduto un blocco identico di 3.190 azioni il 1° luglio 2025 per un ricavo lordo di 1,91 milioni di dollari, indicando una continua cessione delle azioni ricevute in dono. La data prevista per la vendita del nuovo blocco è il 3 luglio 2025 sul NYSE.

Poiché la comunicazione è un avviso di intenzione e non una conferma di esecuzione, e il volume è irrilevante rispetto al totale delle azioni, l’impatto sul mercato è probabilmente minimo. Tuttavia, vendite ricorrenti da parte di insider possono attirare l’attenzione degli investitori sul sentiment interno.

Lennox International Inc. (LII) – Presentación del Formulario 144 revela que John W. Norris III tiene la intención de vender 3,190 acciones del capital común de la empresa. La transacción planeada, que se ejecutará a través de Morgan Stanley Smith Barney LLC, tiene un valor de mercado agregado estimado de 1.92 millones de dólares basado en el precio cotizado en el momento de la presentación. Las acciones representan aproximadamente el 0.009% de las 35.48 millones de acciones en circulación, lo que señala un impacto limitado en la dilución.

Las acciones fueron originalmente recibidas como regalo el 23 de julio de 2009; por lo tanto, la presentación cumple con el requisito de divulgación de la Regla 144 para la reventa de valores restringidos o de control. Una tabla adjunta muestra que el mismo titular ya vendió un bloque idéntico de 3,190 acciones el 1 de julio de 2025 por ingresos brutos de 1.91 millones de dólares, lo que indica una disposición continua de las acciones regaladas. La fecha esperada para la venta del nuevo bloque es el 3 de julio de 2025 en la NYSE.

Dado que la presentación es un aviso de intención, no una confirmación de ejecución, y el volumen es insignificante en relación con el total de acciones, el impacto en el mercado probablemente sea mínimo. No obstante, las ventas recurrentes de insiders pueden atraer la atención de los inversores sobre el sentimiento interno.

Lennox International Inc. (LII) – Form 144 제출은 John W. Norris III가 회사의 보통주 3,190주를 매도할 계획임을 공개합니다. 예정된 거래는 Morgan Stanley Smith Barney LLC를 통해 실행되며, 제출 시점의 시가를 기준으로 추정된 총 시장 가치는 192만 달러입니다. 해당 주식은 전체 3,548만 주 중 약 0.009%에 해당하여 희석 영향이 제한적임을 나타냅니다.

이 주식은 원래 2009년 7월 23일 선물로 받은 것으로, 이번 제출은 제한 주식 또는 내부자 주식 재판매에 관한 규칙 144의 공시 요건을 충족합니다. 첨부된 표에 따르면 동일한 보유자는 이미 2025년 7월 1일에 동일한 3,190주 블록을 매도하여 총 191만 달러의 수익을 올린 바 있습니다, 이는 선물 받은 주식의 지속적인 처분을 의미합니다. 새 블록의 예상 매도일은 2025년 7월 3일이며, NYSE에서 이루어질 예정입니다.

이번 제출은 실행 확인이 아닌 의도 통지이며, 거래량이 전체 주식 대비 미미하므로 시장에 미치는 영향은 최소한일 가능성이 높습니다. 그럼에도 불구하고, 반복적인 내부자 매도는 투자자들의 내부자 심리에 대한 관심을 끌 수 있습니다.

Lennox International Inc. (LII) – Dépôt du formulaire 144 révèle que John W. Norris III a l’intention de vendre 3 190 actions des actions ordinaires de la société. La transaction prévue, qui sera réalisée par l’intermédiaire de Morgan Stanley Smith Barney LLC, représente une valeur marchande totale estimée à 1,92 million de dollars selon le cours du marché au moment du dépôt. Ces actions représentent environ 0,009 % des 35,48 millions d’actions en circulation, indiquant un impact limité sur la dilution.

Les actions ont été initialement reçues en cadeau le 23 juillet 2009 ; par conséquent, le dépôt satisfait à l’exigence de divulgation de la règle 144 pour la revente de titres restreints ou contrôlés. Un tableau annexe montre que le même détenteur a déjà vendu un bloc identique de 3 190 actions le 1er juillet 2025 pour un produit brut de 1,91 million de dollars, ce qui indique une disposition continue des actions reçues en cadeau. La date prévue pour la vente du nouveau bloc est le 3 juillet 2025 à la NYSE.

Étant donné que le dépôt est un avis d’intention et non une confirmation d’exécution, et que le volume est insignifiant par rapport au total des actions, l’impact sur le marché est probablement minime. Néanmoins, des ventes récurrentes d’initiés peuvent attirer l’attention des investisseurs sur le sentiment des initiés.

Lennox International Inc. (LII) – Form 144 Meldung gibt bekannt, dass John W. Norris III beabsichtigt, 3.190 Aktien der Stammaktien des Unternehmens zu verkaufen. Die geplante Transaktion, die über Morgan Stanley Smith Barney LLC abgewickelt wird, hat einen geschätzten Gesamtmarktwert von 1,92 Millionen US-Dollar basierend auf dem zum Zeitpunkt der Meldung notierten Marktpreis. Die Aktien entsprechen etwa 0,009 % der 35,48 Millionen ausstehenden Aktien und deuten auf eine begrenzte Verwässerungswirkung hin.

Die Aktien wurden ursprünglich am 23. Juli 2009 als Geschenk erhalten; somit erfüllt die Meldung die Offenlegungspflicht gemäß Regel 144 für den Wiederverkauf von eingeschränkten oder kontrollierten Wertpapieren. Eine beigefügte Tabelle zeigt, dass derselbe Inhaber bereits am 1. Juli 2025 einen identischen Block von 3.190 Aktien verkauft hat und dabei Bruttoerlöse von 1,91 Millionen US-Dollar erzielte, was auf eine fortgesetzte Veräußerung der geschenkten Aktien hinweist. Das erwartete Verkaufsdatum für den neuen Block ist der 3. Juli 2025 an der NYSE.

Da die Meldung eine Absichtserklärung und keine Ausführungsbestätigung ist und das Volumen im Verhältnis zur Gesamtzahl der Aktien unerheblich ist, dürfte die Marktauswirkung minimal sein. Wiederholte Insiderverkäufe können jedoch die Aufmerksamkeit der Anleger auf die Stimmung der Insider lenken.

Positive
  • Transparent disclosure under Rule 144 demonstrates adherence to SEC requirements.
  • Sale size is immaterial at 0.009% of shares outstanding, implying negligible dilution or market impact.
Negative
  • Continued insider selling (second 3,190-share block within days) may signal reduced insider exposure.
  • Perception risk: Even small sales can be viewed negatively if they form a pattern without insider purchases.

Insights

TL;DR: Small Form 144 sale (~0.009% float); routine, limited price impact, but adds to insider-selling optics.

The 3,190-share sale equates to less than one-hundredth of a percent of Lennox’s outstanding equity, far below Rule 144 volume limits. The shares were gifted, so no direct cost basis signals. Repetition of a similar block two days earlier suggests a pre-arranged 10b5-1 program, mitigating concerns of opportunistic timing. From a liquidity standpoint, $1.9 million is negligible versus LII’s daily trading volume, so price pressure should be minimal. Still, any insider distribution—especially in close succession—can be interpreted as weak confidence, warranting monitoring but not materially altering the investment thesis.

TL;DR: Filing fulfills disclosure duties; transaction size immaterial, governance risk low.

Rule 144 filings demonstrate compliance and transparency. The seller’s representation affirms no undisclosed material information, and the reference to a 10b5-1 plan provides a safe-harbor context. No relationship to the issuer is stated, lessening governance conflict concerns. Given the de minimis stake and procedural adherence, I view governance impact as neutral; continued pattern without offsetting insider purchases could become a perception issue but not a formal red flag.

Lennox International Inc. (LII) – Comunicazione secondo il Modulo 144 rivela che John W. Norris III intende vendere 3.190 azioni del capitale ordinario della società. L’operazione prevista, che sarà effettuata tramite Morgan Stanley Smith Barney LLC, ha un valore di mercato complessivo stimato di 1,92 milioni di dollari basato sul prezzo di mercato quotato al momento della comunicazione. Le azioni rappresentano circa il 0,009% delle 35,48 milioni di azioni in circolazione, indicando un impatto di diluizione limitato.

Le azioni sono state originariamente ricevute come donazione il 23 luglio 2009; pertanto, la comunicazione soddisfa il requisito di divulgazione previsto dalla Regola 144 per la rivendita di titoli soggetti a restrizioni o di controllo. Una tabella allegata mostra che lo stesso detentore aveva già venduto un blocco identico di 3.190 azioni il 1° luglio 2025 per un ricavo lordo di 1,91 milioni di dollari, indicando una continua cessione delle azioni ricevute in dono. La data prevista per la vendita del nuovo blocco è il 3 luglio 2025 sul NYSE.

Poiché la comunicazione è un avviso di intenzione e non una conferma di esecuzione, e il volume è irrilevante rispetto al totale delle azioni, l’impatto sul mercato è probabilmente minimo. Tuttavia, vendite ricorrenti da parte di insider possono attirare l’attenzione degli investitori sul sentiment interno.

Lennox International Inc. (LII) – Presentación del Formulario 144 revela que John W. Norris III tiene la intención de vender 3,190 acciones del capital común de la empresa. La transacción planeada, que se ejecutará a través de Morgan Stanley Smith Barney LLC, tiene un valor de mercado agregado estimado de 1.92 millones de dólares basado en el precio cotizado en el momento de la presentación. Las acciones representan aproximadamente el 0.009% de las 35.48 millones de acciones en circulación, lo que señala un impacto limitado en la dilución.

Las acciones fueron originalmente recibidas como regalo el 23 de julio de 2009; por lo tanto, la presentación cumple con el requisito de divulgación de la Regla 144 para la reventa de valores restringidos o de control. Una tabla adjunta muestra que el mismo titular ya vendió un bloque idéntico de 3,190 acciones el 1 de julio de 2025 por ingresos brutos de 1.91 millones de dólares, lo que indica una disposición continua de las acciones regaladas. La fecha esperada para la venta del nuevo bloque es el 3 de julio de 2025 en la NYSE.

Dado que la presentación es un aviso de intención, no una confirmación de ejecución, y el volumen es insignificante en relación con el total de acciones, el impacto en el mercado probablemente sea mínimo. No obstante, las ventas recurrentes de insiders pueden atraer la atención de los inversores sobre el sentimiento interno.

Lennox International Inc. (LII) – Form 144 제출은 John W. Norris III가 회사의 보통주 3,190주를 매도할 계획임을 공개합니다. 예정된 거래는 Morgan Stanley Smith Barney LLC를 통해 실행되며, 제출 시점의 시가를 기준으로 추정된 총 시장 가치는 192만 달러입니다. 해당 주식은 전체 3,548만 주 중 약 0.009%에 해당하여 희석 영향이 제한적임을 나타냅니다.

이 주식은 원래 2009년 7월 23일 선물로 받은 것으로, 이번 제출은 제한 주식 또는 내부자 주식 재판매에 관한 규칙 144의 공시 요건을 충족합니다. 첨부된 표에 따르면 동일한 보유자는 이미 2025년 7월 1일에 동일한 3,190주 블록을 매도하여 총 191만 달러의 수익을 올린 바 있습니다, 이는 선물 받은 주식의 지속적인 처분을 의미합니다. 새 블록의 예상 매도일은 2025년 7월 3일이며, NYSE에서 이루어질 예정입니다.

이번 제출은 실행 확인이 아닌 의도 통지이며, 거래량이 전체 주식 대비 미미하므로 시장에 미치는 영향은 최소한일 가능성이 높습니다. 그럼에도 불구하고, 반복적인 내부자 매도는 투자자들의 내부자 심리에 대한 관심을 끌 수 있습니다.

Lennox International Inc. (LII) – Dépôt du formulaire 144 révèle que John W. Norris III a l’intention de vendre 3 190 actions des actions ordinaires de la société. La transaction prévue, qui sera réalisée par l’intermédiaire de Morgan Stanley Smith Barney LLC, représente une valeur marchande totale estimée à 1,92 million de dollars selon le cours du marché au moment du dépôt. Ces actions représentent environ 0,009 % des 35,48 millions d’actions en circulation, indiquant un impact limité sur la dilution.

Les actions ont été initialement reçues en cadeau le 23 juillet 2009 ; par conséquent, le dépôt satisfait à l’exigence de divulgation de la règle 144 pour la revente de titres restreints ou contrôlés. Un tableau annexe montre que le même détenteur a déjà vendu un bloc identique de 3 190 actions le 1er juillet 2025 pour un produit brut de 1,91 million de dollars, ce qui indique une disposition continue des actions reçues en cadeau. La date prévue pour la vente du nouveau bloc est le 3 juillet 2025 à la NYSE.

Étant donné que le dépôt est un avis d’intention et non une confirmation d’exécution, et que le volume est insignifiant par rapport au total des actions, l’impact sur le marché est probablement minime. Néanmoins, des ventes récurrentes d’initiés peuvent attirer l’attention des investisseurs sur le sentiment des initiés.

Lennox International Inc. (LII) – Form 144 Meldung gibt bekannt, dass John W. Norris III beabsichtigt, 3.190 Aktien der Stammaktien des Unternehmens zu verkaufen. Die geplante Transaktion, die über Morgan Stanley Smith Barney LLC abgewickelt wird, hat einen geschätzten Gesamtmarktwert von 1,92 Millionen US-Dollar basierend auf dem zum Zeitpunkt der Meldung notierten Marktpreis. Die Aktien entsprechen etwa 0,009 % der 35,48 Millionen ausstehenden Aktien und deuten auf eine begrenzte Verwässerungswirkung hin.

Die Aktien wurden ursprünglich am 23. Juli 2009 als Geschenk erhalten; somit erfüllt die Meldung die Offenlegungspflicht gemäß Regel 144 für den Wiederverkauf von eingeschränkten oder kontrollierten Wertpapieren. Eine beigefügte Tabelle zeigt, dass derselbe Inhaber bereits am 1. Juli 2025 einen identischen Block von 3.190 Aktien verkauft hat und dabei Bruttoerlöse von 1,91 Millionen US-Dollar erzielte, was auf eine fortgesetzte Veräußerung der geschenkten Aktien hinweist. Das erwartete Verkaufsdatum für den neuen Block ist der 3. Juli 2025 an der NYSE.

Da die Meldung eine Absichtserklärung und keine Ausführungsbestätigung ist und das Volumen im Verhältnis zur Gesamtzahl der Aktien unerheblich ist, dürfte die Marktauswirkung minimal sein. Wiederholte Insiderverkäufe können jedoch die Aufmerksamkeit der Anleger auf die Stimmung der Insider lenken.

false 0001158780 0001158780 2025-06-30 2025-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K 

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): July 3, 2025 (June 30, 2025)

 

PLURI INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Nevada   001-31392   98-0351734
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

MATAM Advanced Technology Park     
Building No. 5    
Haifa, Israel   3508409
(Address of Principal Executive Offices)   (Zip Code)

 

011 972 74 710 8600

(Registrant’s telephone number, including area code)

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Shares, par value $0.00001 per share   PLUR   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officer.

 

On June 30, 2025, Pluri Inc. (the “Company”), held its 2025 Annual Meeting of Shareholders (the “2025 Annual Meeting”). As a result of the voting outcome at the 2025 Annual Meeting, Mr. Doron Birger was not re-elected to the Company’s Board of Directors (the “Board”) and therefore ceased to serve as a director and as a member of the respective committees on which he serves, effective immediately. Prior to his departure, Mr. Birger was an independent director, Chairman of the Audit Committee, and the sole member of the Investment Committee.

 

On June 30, 2025, the Company notified The Nasdaq Stock Market LLC (“Nasdaq”) that due to Mr. Birger’s departure, the Company is no longer in compliance with Nasdaq Listing Rule 5605(c)(2)(A), which requires the Audit Committee to be comprised of at least three independent directors. On July 2, 2025, the Company received a letter from the Listing Qualifications Department of Nasdaq, notifying the Company that consistent with Listing Rule 5605(c)(4), Nasdaq will provide the Company a cure period to regain compliance with Nasdaq Listing Rule 5605(c)(2)(A), which will expire on the earlier of (i) the Company’s next annual meeting of shareholders or June 30, 2026, or (ii) if the Company’s next annual meeting of shareholders is held before December 29, 2025, then the Company must evidence compliance no later than June 30, 2026. The Company intends to appoint an additional independent director to the Board and the Audit Committee prior to the expiration of the applicable cure period.

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

On June 30, 2025, the Company held its 2025 Annual Meeting. The results of shareholders voting at the 2025 Annual Meeting are set forth below:

 

Proposal No. 1 - Election of Directors

 

The shareholders cast the following votes for the following individuals nominated as directors of the Company to hold office until the next annual meeting of shareholders and until their successors shall have been duly elected and qualified.

 

Director Name  For   Against   Abstain   Broker
Non-Votes
 
Zami Aberman   3,655,962    37,872    297,831    778,972 
                     
Doron Birger   1,270,717    2,720,350    598    778,972 
                     
Rami Levi   3,977,009    13,754    901    778,972 
                     
Maital Shemesh-Rasmussen   3,974,994    15,840    831    778,972 
                     
Yaky Yanay   3,930,082    60,997    598    778,972 
                     
Alexandre Weinstein   3,942,043    49,033    601    778,972 

 

1

 

 

Proposal No. 2 - Ratification of the selection of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, as independent registered public accounting firm of the Company for the fiscal year ending June 30, 2025.

 

For   Against   Abstain   Broker
Non-Votes
5,164,886   16,289   8,735   N/A

 

Proposal No. 3 – To Consider and approve the Company’s 2016 Equity Compensation Plan.

 

For   Against   Abstain   Broker
Non-Votes
3,914,964   69,257   7,443   778,972

 

Proposal No. 4 – To consider and approve, by a nonbinding advisory vote, the compensation of the Company’s named executive officers as described in the accompanying proxy statement.

 

For   Against   Abstain   Broker
Non-Votes
3,919,160   66,894   5,615   778,972

 

Proposal No. 5 – To recommend, by a nonbinding advisory vote, the frequency (every one, two or three years) of future advisory votes of shareholders on the compensation of our named executive officers.

 

1 Year   2 Years   3 Years   Abstain   Broker
Non-Votes
1,275,471   2,403,566   8,025   304,630   778,972

 

In accordance with the shareholder voting results, in which every “Two Years” received the highest number of votes cast on the frequency proposal, and the Company’s Board of Directors’ recommendation in the proxy statement for the 2025 Annual Meeting, the Company’s Board of Directors has determined that future shareholder advisory (non-binding) votes on the compensation of the Company’s named executive officers will occur every two years. Accordingly, the next shareholder advisory (non-binding) vote on executive compensation will be held at the Company’s 2027 annual meeting of shareholders.

 

Proposal No. 6 – To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the exercise of common warrants and pre-funded warrants to purchase up to 1,086,768 common shares, which were issued pursuant to a Securities Purchase Agreement dated January 23, 2025, as amended by an Amendment to the Securities Purchase Agreement dated April 25, 2025 between the Company and a company wholly beneficially owned by Mr. Alexandre Weinstein, relating to a private placement offering.

 

For   Against   Abstain   Broker
Non-Votes
3,530,251   47,936   5,668   778,972

 

The vote total set forth above with respect to Proposal No. 6 excludes shares beneficially owned by Mr. Alexandre Weinstein, which were not counted for purposes of such proposal, as the securities underlying the exercise of warrants and pre-funded warrants are to be issued pursuant to a private placement between the Company and an entity wholly beneficially owned by Mr. Alexandre Weinstein.

 

The results reported above are final voting results.

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PLURI INC.
   
Date: July 3, 2025 By: /s/ Liat Zalts
  Name:   Liat Zalts
  Title: Chief Financial Officer

 

3

FAQ

How many Lennox International (LII) shares are being sold under this Form 144?

The filing covers 3,190 common shares.

What is the estimated market value of the proposed LII share sale?

The aggregate market value is approximately $1.92 million.

When is the anticipated sale date for these LII shares?

The filer lists an approximate sale date of 3 Jul 2025.

How significant is the sale relative to Lennox’s total shares outstanding?

The block represents about 0.009% of 35.48 million shares outstanding, a very small proportion.

Were any LII shares sold recently by the same individual?

Yes, an identical 3,190-share sale occurred on 1 Jul 2025 for gross proceeds of $1.91 million.
Pluri Inc

NASDAQ:PLUR

PLUR Rankings

PLUR Latest News

PLUR Latest SEC Filings

PLUR Stock Data

45.51M
4.45M
42.57%
10.38%
0.37%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
Israel
HAIFA